| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14656566.3.5.619 |
| P698 | PubMed publication ID | 11996639 |
| P2093 | author name string | Naiel Nassar | |
| Philip Keiser | |||
| P2860 | cites work | Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. | Q34088490 |
| Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study | Q34091370 | ||
| A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects | Q42687040 | ||
| Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity | Q43532377 | ||
| Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with each component administered concurrently and the effect of food on absorption | Q43554149 | ||
| A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults | Q43580186 | ||
| Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response | Q43759312 | ||
| Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir | Q43760231 | ||
| Hypersensitivity related to abacavir in two members of a family | Q43776204 | ||
| Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial | Q32084749 | ||
| Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel | Q33824632 | ||
| Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults | Q33980172 | ||
| Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. | Q33993644 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 619-624 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Trizivir | |
| P478 | volume | 3 |
| Q34778565 | A review of the pharmacokinetics of abacavir | cites work | P2860 |
Search more.